CDY2B

Across TCGA pan-cancer cohorts, CDY2B RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated CDY2B data layer compared with 1 for mass-spec protein.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher CDY2B RNA is associated with worse overall survival. In most high-consensus cancer types, elevated CDY2B expression acts as an unfavorable survival marker.

LUAD, OV, and READ are the cancer types where CDY2B RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Tertile	All	0.158	0.835	<.001	108	view →
OV	DFS	Tertile	II,III,IV	0.275	0.542	.039	36	view →
READ	OS	Tertile	II,III,IV	0.187	0.644	.023	36	view →
ESCA	OS	Tertile	All	0.198	0.872	.003	36	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

CDY2B–LUAD (OS)

Open the LUAD breakdown →